MicroPort Endovascular MedTech Ltd - Asset Resilience Ratio
MicroPort Endovascular MedTech Ltd (688016) has an Asset Resilience Ratio of 20.69% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2025–2025)
This chart shows how MicroPort Endovascular MedTech Ltd's Asset Resilience Ratio has changed over time. Check MicroPort Endovascular MedTech Ltd (688016) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down MicroPort Endovascular MedTech Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is MicroPort Endovascular MedTech Ltd worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥991.66 Million | 20.69% |
| Total Liquid Assets | CN¥991.66 Million | 20.69% |
Asset Resilience Insights
- Good Liquidity Position: MicroPort Endovascular MedTech Ltd maintains a healthy 20.69% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
MicroPort Endovascular MedTech Ltd Industry Peers by Asset Resilience Ratio
Compare MicroPort Endovascular MedTech Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM |
Medical Devices | 46.67% |
|
Allmed Solutions Ltd
TA:ALMD |
Medical Devices | 80.03% |
|
Universal Biosensors Inc
AU:UBI |
Medical Devices | 14.72% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
Annual Asset Resilience Ratio for MicroPort Endovascular MedTech Ltd (2025–2025)
The table below shows the annual Asset Resilience Ratio data for MicroPort Endovascular MedTech Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.16% | CN¥100.37 Million ≈ $14.69 Million |
CN¥4.64 Billion ≈ $679.15 Million |
-- |
About MicroPort Endovascular MedTech Ltd
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft syste… Read more